Enveric Biosciences, Inc., 2025-12-23
An SEC Form D private-offering notice from Cambridge, MA, a $106,598 filer-stated offering target in Biotech. Filed 2025-12-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotechnology company developing neuroplastogenic small molecules for psychiatric and neurological disorders, traded on Nasdaq as ENVB.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- QuantumSafe Data Systems Inc., 2025-12-23, $12.6M, Norwell, MA
- Koios Medical, Inc., 2025-12-23, New York, NY
- Square Robot, Inc., 2025-12-23, $15M, Westborough,, MA
- Cytogel Pharma, LLC, 2025-12-23, $16M, Darien, CT
- Mediar Therapeutics, Inc., 2025-12-23, $75.7M, Boston, MA
- Myrtelle Inc., 2025-12-23, $55.2M, New York, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.